Ticker: CO, Company: China Cord Blood Corp, Type: 20-F, Date: 2013-07-31, XBRL Interactive Financials
Original SEC Filing: Click here

---

Webplus: CO/20130731/20-F/1/000.htm SEC Original: v349858_20f.htm
TABLE OFNTENTS PART I 4 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT ANDVISERS 4 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 4 ITEM 3. KEY INFORMATION 4 A. Selected financialta 4 B.pitalization and Indebtedness 6 C. Reasons for the Offer and Use of Proceeds 7 D. Risk factors

---

---

Webplus: CO/20130731/20-F/2_EX-4.24/000.htm SEC Original: v349858_ex4-24.htm
Guangzhou City Real Estate Property Purchasereement Seller (Party A):Guangzhou Hezhong CD Manufacturing Legal Representative:ZHU Suifeng Buyer (Party B):Guangzhou Municipality Tianhe Nuoya Bio-engineering Legal Representative:ZHENG Ting Article IParty A desires to transfer the real estate property it owns,luding the land use right to the surrounding public green area and road (See Property Layout Plan attached for

---

---

Webplus: CO/20130731/20-F/3_EX-4.25/000.htm SEC Original: v349858_ex4-25.htm
Hundsun (Hangzhou)ience & Technology Park Property Transferreementntract #: H216 ( Party A (Transferor): Hangzhou Hundsun Baichuan Technology Legal Representative: HU Weiguo Party B (Transferee): Beijing Jiachenhong Biological Technologies Legal Representative: DENG Yue Article IBackground of thenstruction Project Party A entered into anreement Statenstruction Land Use Right Transferntract (contract No. 3301102009A21063) with Hangzhou Municipal Bureau of

---

---

Webplus: CO/20130731/20-F/4_EX-8.1/000.htm SEC Original: v349858_ex8-1.htm
List of Subsidiaries Name Jurisdiction Chinard Blood Servicesrporationyman Islands China Stem Cellss Limitedyman Islands Beijing Jiachenhong Biological Technologies Peoples Republic of China Guangzhou Municipality Tianhe Nuoya Bio-engineering Peoples Republic of China Zhejiang Lukou Biotechnology Peoples Republic of China China Stem Cells (East)mpany Limited

---

---

Webplus: CO/20130731/20-F/5_EX-12.1/000.htm SEC Original: v349858_ex12-1.htm
Certification I, Ting Zheng, certify that: 1. I have reviewed this annual report on Form 20-F of Chinard Bloodrporation; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which

---

---

Webplus: CO/20130731/20-F/6_EX-12.2/000.htm SEC Original: v349858_ex12-2.htm
Certification I,bert Chen, certify that: 1. I have reviewed this annual report on Form 20-F of Chinard Bloodrporation; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such

---

---

Webplus: CO/20130731/20-F/7_EX-13.1/000.htm SEC Original: v349858_ex13-1.htm
Certification CHINARD BLOODRPORATION July 31, 2013 Ting Zheng Chief Executive Officer July 31, 2013bert Chen Chief Financial Officer (Principal Financial and Accounting Officer) v349858_ex13-1.htm 7 EX-13.1

---

---

Webplus: CO/20130731/20-F/8_EX-15.1/000.htm SEC Original: v349858_ex15-1.htm
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM The Board of Directors Chinard Bloodrporation: Hong Kong, China July 31, 2013 v349858_ex15-1.htm 8 EX-15.1

---

Company Information:

Ticker: CO, Company: China Cord Blood Corp, Type: 20-F, Date: 2013-07-31, XBRL Interactive FinancialsCIK: 0001467808, Location: K3, SIC: 6770, SIC Desc: BLANK CHECKS
Business Phone & Address:
48 FL., BANK OF CHINA TOWER, 1 GARDEN ROAD
CENTRAL HONG KONG, K3 000000